• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM XC; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 45007
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Obstruction/Occlusion (2422); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440)
Event Date 10/03/2023
Event Type  Injury  
Event Description
It was reported that dissection, distal embolization, and thrombotic occlusion occurred, and the patient had a subsequent amputation.On 26-sep-2023, this 2.4mm jetstream xc catheter was selected for use in an endovascular therapy procedure.The 75% stenosed, severely calcified, moderately tortuous lesion was located in the right superficial femoral artery (sfa).During the procedure, this jetstream device was used to perform lesion ablation with 2 to 3 passes in blades down, and 2 to 3 passes in blades up.After confirming that sufficient ablation was performed and no major problems occurred such as dissection during contrast imaging, the lesion was dilated with a ranger 6.0/200mm balloon.The procedure was then completed after confirming that there was good dilatation, and no major problems were noticed during final angiography.Final contrast imaging was performed; however, the contrast was unable to reach the toes.Several days post procedure, the patient complained of pain in the right lower extremity.Contrast imaging revealed the common femoral artery was thrombotic and occluded; therefore, the patient was transferred to the hospital.They attempted to improve blood flow with a non-boston scientific device for thrombotic occlusion.However, the expected result was not obtained; therefore, the patient was transferred to a different hospital and underwent a major amputation on 20-oct-2023.It was later reported that thrombus occurred because the lesion in the sfa ostium was not treated.It was also reported that a dissection had formed in the area cut with the jetstream device which had been overlooked, and a blood clot formed in that area.Additionally, there was a distal embolization at a level that was not visible to the naked eye, and due to a combination of factors, the distal embolization progressed to thrombotic occlusion.
 
Manufacturer Narrative
The complaint device was not received at the complaint investigation site (cis) for analysis.Medical and media review of angiogram performed on 9/26/2023 at the time of the jetstream procedure, and the follow up angiogram on 10/14/2023, was completed.Arteriography performed on 9/26/2023, shows no below knee runoff was provided, but flow on the images appear adequate.Arteriography on 10/14/2023 demonstrates complete occlusion of the right cfa and no infrainguinal artery opacification.There is no evidence of distal embolization on any of the arteriograms provided.As a result, of the medical and media review, distal embolization cannot be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM XC
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18156285
MDR Text Key328351901
Report Number2124215-2023-61200
Device Sequence Number1
Product Code MCW
UDI-Device Identifier08714729889922
UDI-Public08714729889922
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K133023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number45007
Device Catalogue Number45007
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
RANGER, JUPITER FC
Patient Outcome(s) Required Intervention; Other;
-
-